Canadian Inborn Errors of Immunity National Registry – an observational, longitudinal research study design for a Rare Disease Registry Model with Governance Framework and Enhanced Interoperability
Year: 2026
Type: preprint
Abstract: Background Inborn errors of immunity (IEI) are individually rare but collectively affect an estimated 30,000 Canadians. Their genetic and clinical heterogeneity, combined with limited disease-specific data, presents challenges in diagnosis, management, and evaluation of treatment outcomes. A national registry with standardized longitudinal data collection is needed to better characterize disease manifestations, support clinical research, inform healthcare planning, and improve care for individuals with IEI across Canada. Methods A national steering committee comprising 13 clinician-researchers from 3 adult and 8 pediatric centres across 9 Canadian provinces established the Canadian Inborn Errors of Immunity National Registry (CIEINR). Development was informed by an environmental scan of existing rare disease registries and consultations with bioinformatics experts and patient representatives. A multidomain electronic case report form (eCRF) was developed using Research Electronic Data Capture (REDCap), hosted at the University of Calgary, to systematically collect demographic, genetic, clinical, treatment, and outcome data. Results Between 2021 and 2025, the CIEINR governance framework, research protocols, and standardized data model were developed and peer-reviewed. The eCRF incorporates ontology-based medical terminologies to facilitate standardized characterization of clinical manifestations, data harmonization, and interoperability. The RareLink framework was adapted to support internationally standardized data linkage and generation of Global Alliance for Genomics and Health (GA4GH) Phenopackets, enabling structured, machine-readable representation of clinical and genomic information. Registry governance documents, policies, and data models are shared through an open-access GitHub repository to promote transparency, reproducibility, and collaboration. Conclusions The innovative CIEINR provides a national infrastructure for standardized, longitudinal collection of diagnosis, disease course, treatment, outcomes, and genomic data ac across the spectrum of IEI. High-quality, standardized, machine-readable, and interoperable data will enable Phenopacket analysis, support research on new therapies, and foster international collaboration. By openly sharing its governance framework, policies, and data model, CIEINR establishes a reproducible approach to rare disease registry development while advancing evidence-based clinical care, patient advocacy, and healthcare policy.
Source: Research Square
Authors: Tatiana Kalashnikova(Conceptualization), Ashley V. Geerlinks, Adam S.L. Graefe, Taylor Mattinson, Hanna Huska, Eyal Grunebaum(Conceptualization), Sneha Suresh(Conceptualization), Bruce Ritchie(Conceptualization), Juthaporn Cowan(Conceptualization), Tamar Rubin(Conceptualization), Luis Murguía-Favela, Jennifer K. Grossman, Alyssa Alger, Mandi Uppal, Rae Brager(Conceptualization), Hugo Chapdelaine(Conceptualization), Catherine Biggs(Conceptualization), Brenda Turley, Candace Rusling, Lavindu Senadheera, Whitney Goulstone(Conceptualization), Rouven Reuter, Daniel Danis, Sylvia Thun, Peter N. Robinson, Oya Beyan, Nicola AM Wright, Beata Derfalvi(Conceptualization)
Institutions: University of Calgary, Alberta Children's Hospital, Western University, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité – Universitätsmedizin Berlin, Dalhousie University, University of Toronto, University of Alberta, University of Ottawa, Children's Hospital of Winnipeg, University of Manitoba, Alberta Health Services, McMaster Children's Hospital, McMaster University, Université de Montréal, University of British Columbia, University Hospital Cologne
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7235982844
